Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study

BackgroundFatty liver index (FLI) calculated by using body mass index, waist circumference and levels of triglycerides and γ-glutamyl transpeptidase is a noninvasive biomarker for diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD), which is one of the high-risk conditions...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Yasutaka Takeda, Masato Furuhashi, Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Naoki Kumashiro, Masaru Sakurai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	fatty liver index atherosclerotic cardiovascular disease residual risk hypertriglyceridemia nonalcoholic fatty liver disease metabolic dysfunction-associated fatty liver disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1549687/full